Published in BMJ on July 21, 2001
Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ (2003) 18.72
British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax (2003) 5.83
The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ (2009) 4.18
Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis. BMJ (2013) 2.45
Risk factors for venous and arterial thrombosis. Blood Transfus (2010) 1.58
Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain (2012) 1.40
Effects of switching from oral to transdermal or transvaginal contraception on markers of thrombosis. Contraception (2008) 1.40
Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies? Br J Clin Pharmacol (2008) 1.33
Diane-35 (cyproterone acetate): safety concerns. CMAJ (2003) 1.22
Deep vein thrombosis and pulmonary embolism reported in the Prescription Event Monitoring Study of Yasmin. Br J Clin Pharmacol (2005) 1.19
The Risk of Venous Thromboembolism with Different Generation of Oral Contraceptives; a Systematic Review and Meta-Analysis. Emerg (Tehran) (2014) 1.04
Contraceptive efficacy of oral and transdermal hormones when co-administered with protease inhibitors in HIV-1-infected women: pharmacokinetic results of ACTG trial A5188. J Acquir Immune Defic Syndr (2010) 1.02
Systematic review of methods used in meta-analyses where a primary outcome is an adverse or unintended event. BMC Med Res Methodol (2012) 1.01
The third generation pill controversy ("continued"). BMJ (2001) 0.92
Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ (2012) 0.90
Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients. Vasc Health Risk Manag (2007) 0.86
Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis. J Clin Endocrinol Metab (2013) 0.85
The association between drospirenone and hyperkalemia: a comparative-safety study. BMC Clin Pharmacol (2011) 0.84
Influence of the third generation pill controversy on prescriptions for oral contraceptives among first time users: population based study. BMJ (2003) 0.83
Safety, efficacy and patient satisfaction with continuous daily administration of levonorgestrel/ethinylestradiol oral contraceptives. Patient Prefer Adherence (2009) 0.81
Comparative study of the effects of combined oral contraceptives in hemostatic variables: an observational preliminary study. Medicine (Baltimore) (2015) 0.80
Mortality from venous thromboembolism in young Swedish women and its relation to pregnancy and use of oral contraceptives--an approach to specifying rates. Eur J Epidemiol (2005) 0.79
The Sexual Acceptability of Contraception: Reviewing the Literature and Building a New Concept. J Sex Res (2016) 0.77
Inherited thrombophilia and stratification of ischaemic stroke risk among users of oral contraceptives. J Neurol Neurosurg Psychiatry (2006) 0.76
International Active Surveillance Study of Women Taking Oral Contraceptives (INAS-OC Study). BMC Med Res Methodol (2009) 0.75
Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome. Ther Clin Risk Manag (2015) 0.75
Pulmonary embolism and deep vein thrombosis related to oral contraceptive use. Obstet Gynecol Sci (2013) 0.75
The contraceptive revolution: some excellent progress but work still to be done. Br J Gen Pract (2009) 0.75
Contraception in women with medical problems. Obstet Med (2008) 0.75
Hormonal Contraception Use is Common Among Patients with Inflammatory Bowel Diseases and an Elevated Risk of Deep Vein Thrombosis. Inflamm Bowel Dis (2016) 0.75
Oral contraceptives, venous thromboembolism, and the courts. BMJ (2002) 0.75
The association of statin use with reduced incidence of venous thromboembolism: a population-based cohort study. BMJ Open (2014) 0.75
[Venous thromboembolic disease in the region of Sidi Bel Abbes, Algeria: frequency and risk factors]. Pan Afr Med J (2013) 0.75
The new extended-cycle levonorgestrel-ethinyl estradiol oral contraceptives. Clin Med Insights Reprod Health (2011) 0.75
Hormonal contraceptives and cerebral venous thrombosis risk: a systematic review and meta-analysis. Front Neurol (2015) 0.75
The hazards of scoring the quality of clinical trials for meta-analysis. JAMA (1999) 17.00
Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med (1998) 11.14
Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet (1995) 7.55
Population-based study of risk of venous thromboembolism associated with various oral contraceptives. Lancet (1997) 6.24
Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet (1995) 5.10
A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med (1994) 5.04
Venous thromboembolism among new users of different oral contraceptives. Lancet (1999) 3.25
The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women. Contraception (1996) 3.23
Oral contraceptives and the risk of venous thrombosis. N Engl J Med (2001) 2.57
First-time use of newer oral contraceptives and the risk of venous thromboembolism. Contraception (1997) 2.27
Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias. Arch Intern Med (1999) 1.95
A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives. Br J Clin Pharmacol (2000) 1.84
The differential risk of oral contraceptives: the impact of full exposure history. Hum Reprod (1999) 1.78
Newer oral contraceptives and the risk of venous thromboembolism. Contraception (1998) 1.67
The risk of venous thromboembolism in users of postcoital contraceptive pills. Contraception (1999) 1.62
Third-generation oral contraceptive and deep venous thrombosis: from epidemiologic controversy to new insight in coagulation. Am J Obstet Gynecol (1997) 1.59
Oral contraceptives and thrombotic diseases: impact of new epidemiological studies. Contraception (1996) 1.48
Confounding and indication for treatment in evaluation of drug treatment for hypertension. BMJ (1997) 1.34
Oral contraceptives and venous thromboembolism. A case-control study. Contraception (1998) 1.33
Cardiovascular disease and combined oral contraceptives: reviewing the evidence and balancing the risks. Hum Reprod Update (2000) 1.25
Venous thromboembolic disease and combined oral contraceptives: A re-analysis of the MediPlus database. Hum Reprod (1999) 1.17
Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis. Arterioscler Thromb Vasc Biol (1999) 1.12
Recurrent use of newer oral contraceptives and the risk of venous thromboembolism. Hum Reprod (2000) 1.06
Scoring the quality of clinical trials. JAMA (2000) 1.00
Oral contraceptives and venous thromboembolic disease. Analyses of the UK General Practice Research Database and the UK Mediplus database. Hum Reprod Update (2000) 1.00
Third generation oral contraceptives and heritable thrombophilia as risk factors of non-fatal venous thromboembolism. Thromb Haemost (1998) 0.98
The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study. Acta Obstet Gynecol Scand (1997) 0.97
Venous thromboembolism and combined oral contraceptives: does the type of progestogen make a difference? Contraception (2000) 0.96
Smoking and use of oral contraceptives: impact on thrombotic diseases. Am J Obstet Gynecol (1999) 0.90
The risks of venous thromboembolic disease among German women using oral contraceptives: a database study. Contraception (1998) 0.85
Oral contraceptives and thrombotic diseases: impact of new epidemiological studies. Contraception (1996) 0.81
Recent oral contraceptive use patterns in four European countries: evidence for selective prescribing of oral contraceptives containing third-generation progestogens. Eur J Contracept Reprod Health Care (1998) 0.81
The Transnational Study on Oral Contraceptives and the Health of Young Women. Methods, results, new analyses and the healthy user effect. Hum Reprod Update (2000) 0.81
Selective prescribing of third generation oral contraceptives (OCs). Contraception (1996) 0.81
Oral contraception was not associated with venous thromboembolic disease in recent study. BMJ (1998) 0.80
Oral contraceptives and venous thromboembolic disease: the findings from database studies in the United Kingdom and Germany. Am J Obstet Gynecol (1998) 0.80
Resistance to activated protein C, highly prevalent amongst users of oral contraceptives with venous thromboembolism. J Intern Med (1998) 0.80
The aftermath of a pill scare: regression to reassurance. Hum Reprod Update (2000) 0.79
Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet (2006) 10.72
Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol (1991) 7.67
Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation (1997) 7.03
Oral contraceptives and the risk of myocardial infarction. N Engl J Med (2001) 5.18
Diuretics, beta-blockers, and the risk for sudden cardiac death in hypertensive patients. Ann Intern Med (1995) 5.12
The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology (1995) 5.08
Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet (1997) 5.04
Cardiovascular mortality in Dutch men during 1996 European football championship: longitudinal population study. BMJ (2001) 4.87
The epidemiology of heart failure. Eur Heart J (1997) 4.31
Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke (1997) 4.13
Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke (1998) 4.12
Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke (2001) 3.99
Early outcome after off-pump versus on-pump coronary bypass surgery: results from a randomized study. Circulation (2001) 3.96
J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet (1994) 3.95
Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology (1994) 3.75
Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke (1996) 3.67
Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke (2003) 3.56
External validation is necessary in prediction research: a clinical example. J Clin Epidemiol (2003) 3.49
Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. Lancet (2005) 3.46
Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ (1995) 3.42
Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol (1998) 3.37
The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology (1994) 3.30
Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J (1999) 3.18
Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry (2007) 3.17
The prognosis of heart failure in the general population: The Rotterdam Study. Eur Heart J (2001) 3.07
Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Circulation (2005) 2.99
Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia (1997) 2.82
Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet (1998) 2.82
Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol (1996) 2.80
Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke (1997) 2.79
Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam Study. Ann Intern Med (1995) 2.70
Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke (2005) 2.69
Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ (1994) 2.60
Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med (1999) 2.53
Is carotid intima-media thickness useful in cardiovascular disease risk assessment? The Rotterdam Study. Stroke (2001) 2.49
How to assess the external validity of therapeutic trials: a conceptual approach. Int J Epidemiol (2009) 2.49
Treatment of intracranial aneurysms by embolization with coils: a systematic review. Stroke (1999) 2.49
Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study. Am J Epidemiol (1996) 2.45
A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab (1998) 2.45
Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology (1995) 2.43
Does drug treatment improve survival? Reconciling the trials in mild-to-moderate hypertension. J Hypertens (1995) 2.40
Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology (1998) 2.39
Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab (2000) 2.36
Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med (2001) 2.35
Association of intraoperative transcranial doppler monitoring variables with stroke from carotid endarterectomy. Stroke (2000) 2.33
Comparison between measures of atherosclerosis and risk of stroke: the Rotterdam Study. Stroke (2003) 2.31
Circle of Willis: morphologic variation on three-dimensional time-of-flight MR angiograms. Radiology (1998) 2.30
Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology (1995) 2.30
Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis. Lancet (2001) 2.29
Limitations of sensitivity, specificity, likelihood ratio, and bayes' theorem in assessing diagnostic probabilities: a clinical example. Epidemiology (1997) 2.28
Carotid intima-media thickness at different sites: relation to incident myocardial infarction; The Rotterdam Study. Eur Heart J (2002) 2.22
Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study. J Neurol Neurosurg Psychiatry (2003) 2.18
QTc dispersion predicts cardiac mortality in the elderly: the Rotterdam Study. Circulation (1998) 2.15
Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study. Stroke (1994) 2.14
Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation (1995) 2.13
Postprandial triglyceride response in young adult men and familial risk for coronary atherosclerosis. Ann Intern Med (1994) 2.11
Preoperative prediction of severe postoperative pain. Pain (2003) 2.11
Increase in hospital admission rates for heart failure in The Netherlands, 1980-1993. Heart (1996) 2.10
Low testosterone concentrations and the symptoms of testosterone deficiency according to the Androgen Deficiency in Ageing Males (ADAM) and Ageing Males' Symptoms rating scale (AMS) questionnaires. Clin Endocrinol (Oxf) (2011) 2.09
Prolonged QT interval predicts cardiac and all-cause mortality in the elderly. The Rotterdam Study. Eur Heart J (1999) 2.09
Associations of radiological osteoarthritis of the hip and knee with locomotor disability in the Rotterdam Study. Ann Rheum Dis (1998) 2.08
Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2007) 2.08
Ticlopidine, trials, and torture. Stroke (1994) 2.04
Distribution of central corneal thickness and its association with intraocular pressure: The Rotterdam Study. Am J Ophthalmol (1997) 2.04
[Nutrition and health--hypertension]. Ned Tijdschr Geneeskd (2003) 2.04
[Short preoperative health assessment proposed by the Health Council not useful in clinical practice]. Ned Tijdschr Geneeskd (2001) 2.04
Secondary prevention after cerebral ischaemia of presumed arterial origin: is aspirin still the touchstone? J Neurol Neurosurg Psychiatry (1999) 2.03
Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol (1995) 2.02
Updating methods improved the performance of a clinical prediction model in new patients. J Clin Epidemiol (2007) 2.01
Application of treatment thresholds to diagnostic-test evaluation: an alternative to the comparison of areas under receiver operating characteristic curves. Med Decis Making (1997) 1.96
Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials. J Hum Hypertens (2003) 1.96
Follow-up screening after subarachnoid haemorrhage: frequency and determinants of new aneurysms and enlargement of existing aneurysms. Brain (2005) 1.85
Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension. BMJ (1994) 1.83
Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia (1996) 1.82
Mortality and morbidity of surgery for unruptured intracranial aneurysms: a meta-analysis. Stroke (1998) 1.82
Recurrent ischemia in symptomatic carotid occlusion: prognostic value of hemodynamic factors. Neurology (2000) 1.80
Relation between birth weight and blood pressure: longitudinal study of infants and children. BMJ (1993) 1.76
T axis as an indicator of risk of cardiac events in elderly people. Lancet (1998) 1.75
Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. Eur Heart J (2003) 1.74
Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials. J Hum Hypertens (2006) 1.74
Low serum cholesterol concentration and serotonin metabolism in men. BMJ (1996) 1.74
Long-term effects of neonatal sodium restriction on blood pressure. Hypertension (1997) 1.74
Changes in functional outcome and quality of life in patients and caregivers after aneurysmal subarachnoid hemorrhage. J Neurosurg (2001) 1.73
Association of radiographically evident osteoarthritis with higher bone mineral density and increased bone loss with age. The Rotterdam Study. Arthritis Rheum (1996) 1.72
Course of the international Normalized Ratio in response to oral vitamin K1 in patients overanticoagulated with phenprocoumon. Br J Haematol (1999) 1.69
Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART Study (Second Manifestations of ARTerial disease). Circulation (1999) 1.69
Risk of cardiac events in atypical transient ischaemic attack or minor stroke. The Dutch TIA Study Group. Lancet (1992) 1.68
First contact incidence of psychotic disorders among native Dutch and Moroccan immigrants in the Netherlands: influence of diagnostic bias. Schizophr Res (2010) 1.68
Blood pressure in childhood: pooled findings of six European studies. J Hypertens (1991) 1.68
Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance. Hum Genet (1997) 1.66
Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly: the Rotterdam study. Circulation (2002) 1.66
Increased risk of atherosclerosis in women after the menopause. BMJ (1989) 1.66
Employment grade differences in cause specific mortality. A 25 year follow up of civil servants from the first Whitehall study. J Epidemiol Community Health (2000) 1.65
Primary open-angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population. The Rotterdam Study. Ophthalmology (1996) 1.65
Cognitive impairment in tuberous sclerosis complex is a multifactorial condition. Neurology (2007) 1.64
Exhaled nitric oxide in 4-year-old children: relationship with asthma and atopy. Eur Respir J (2005) 1.62
Subarachnoid haemorrhage in first and second degree relatives of patients with subarachnoid haemorrhage. BMJ (1995) 1.62